Arbutus to Report Second Quarter 2024 Financial Results and Provide Corporate Update
July 18, 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Texas Capital Bancshares, Inc. Announces Second Quarter 2024 Results
July 18, 2024 06:00 ET
|
Texas Capital Bancshares, Inc.
Second quarter 2024 net income of $41.7 million and net income available to common stockholders of $37.4 million, or $0.80 per diluted share Book Value and Tangible Book Value(1) per share both...